Promoting diversity among patients, providers, and outcomes (And research needed in those areas)

Income versus cost of living for REIs (Big cities vs. small)

Establishing REI Fellowships in states without existing programs

Talking about access to broader IVF care versus providing it

Her definition of personalized care (Contrasting with what is being done today)

The micro & macro of what’s happening in the IVF field

New technologies improving efficacy & efficiency (And where the two come together)

AIVF’s innovations allowing embryologists to do more cycles more effectively (And its impact on the embryo) 

How this same technology can provide non-invasive genetic screening.

Her 2 objectives for REI Fellowship (that every REI should have)

The criteria for choosing an REI practice (when navigating the interview process)

Why she prefers a bigger practice over a smaller one

Where she stands on the Fellowship length debate (3 years or 2)

What she’d like the fertility field to look like in 20 years

Why, in her view, research in REI has atrophied

Her robust definition of a Privademic Practice (and their advantages)  

How Privademics can adopt new technologies faster (with a higher standard of quality control)

The specific research she believes is needed to improve innovation

Current technologies she’s paying attention to

Some great examples of how he’s proven concept (both functionality & market value)

The conditions for bootstrapping without a proven concept

How Cycle Clarity gave equity to early employees (and how you might be able to do the same)

Your biggest opportunities in the years to come (From egg retrievals to streamlining ovulation induction)

How to bring patient education into the culture

Non-Selection Studies and how you may be leading them

The unique opportunities the Prelude Network offers (Like pioneering research at the Prelude Research Institute)

How one legacy career leads to another: Yours.

The essentials to staying compliant with the FDA

How to properly counsel patients on 3rd party options: Dr. Best’s tips

What to tell donors during the application process (And what to tell them if they’re not selected)

Processes currently impeding more 3rd party IVF cases (But how new technologies are changing that)

Dr. Shapiro’s hard-won lessons from running an egg bank

The 5 ancillary services of the fertility space (And how they make the distinction between vertical and horizontal integration)

The argument against concentrating these services (Like risking new buckets of liability)

The argument for concentrating these services (The sweet spot to acquiring a related service)

Backward integration vs Forward integration (Move closer to raw materials or toward end patient consumers?)

A breakdown of the recent major lawsuits in fertility (And what those would look like in a vertically integrated fertility space)

Speculation on when we could expect to see antitrust regulation in the field

The differences between starting, expanding, and moving your office [And the unique considerations of each]

The difference between building a new office and moving into an existing building [With and without a lab]

When to Buy vs. when to Lease

The non-negotiables that should go into a letter of intent for a new lease

Building a Standard Operating Procedure for launching new locations [So organizations can do it at scale]

How she selects vendors for each new site